Filter by Date
Showing 50 results for "AmGen"
Order by:
Education 14 Dec 2024 | 11:00 PM

Amgen Scholars Programme (ASP)

The ASP, an international programme funded by the Amgen Foundation, provides hundreds of selected undergraduates with the opportunity to engage in a hands-on research experience at many of the world’s leading educational institutions.

World 26 Feb 2021 | 02:27 PM

AstraZeneca-Amgen drug could widen treatment options for severe asthma

(Reuters) - AstraZeneca and Amgen's experimental drug reduced asthma attacks in patients with severe and uncontrolled forms of the respiratory condition in a large study, showing promise for wider use against different triggers.

Technology 26 Feb 2025 | 03:42 PM

At conference, drugmakers tout AI efforts as US tariffs cast shadow

HYDERABAD (Reuters) - The rising adoption of artificial intelligence in the pharmaceutical industry dominated discussions at a conference in India this week, while executives largely preferred to wait for more clarity on U.S. President Donald Trump's tariff threats.

Banking 20 Feb 2025 | 05:19 AM

AMMB stays on track with WT29 strategy, delivers strong 9MFY25 earnings

KUALA LUMPUR: AMMB Holdings Bhd is on track with its refreshed Winning Together (WT29) strategy and is optimistic about its prospects in the current financial year ending March 31, 2025 (FY25).

World 26 Nov 2024 | 06:31 PM

New U.S. drug causes 20 pct weigh loss in early results: report

NEW YORK, Nov. 26 (Xinhua) -- The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose an average of up to 20 percent of their weight in a year.

Markets 26 Nov 2024 | 11:20 PM

Wall Street ends higher on tech stocks

Wall Street stocks, led by S&P 500 and the Nasdaq, ended higher on Tuesday, as technology stocks rebounded, while investors digested President-elect Donald Trump's tariff pledges on top trade partners and the latest minutes from the Federal Reserve.

Banking 27 Nov 2024 | 05:40 AM

AmBank CEO optimistic over progress in FY25

KUALA LUMPUR: AMMB Holdings Bhd (AmBank) said it is optimistic over its prospects in FY25 now it has arrived at the halfway mark with an improved performance over the previous year.

M&A 17 May 2023 | 11:00 PM

Pfizer sells US$31bil of bonds

Pfizer Inc has sold US$31bil (RM140bil) of debt in the fourth-largest US bond sale ever, according to a source.

Markets 3 May 2024 | 01:10 PM

Wall St set to open sharply higher on soft jobs data

WALL Street's main indexes were set to open higher on Friday after a softer-than-expected jobs report revived hopes of the Federal Reserve cutting interest rates this year, while gains in Apple and Amgen on upbeat corporate updates added support.

Corporate News 5 Nov 2024 | 11:00 PM

Obesity pill data signal competition and hit drugmaker shares

Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field.

Markets 25 Sept 2024 | 11:30 PM

S&P 500, Dow end lower as investors await rate signals

The Dow Jones Industrial Average and S&P 500 closed lower on Wednesday, pulling back from recent record highs driven by China's sweeping stimulus package, as investors awaited economic indicators and signals on upcoming interest rate cuts.

Insight 22 Nov 2023 | 11:00 PM

How broker dealers dented Wall Street’s huge diversity gap

When drugmaker Amgen Inc sold US$24bil of bonds in February to fund its takeover of Horizon Therapeutics Plc, it had 12 banks as joint bookrunners and a further 16 as co-managers on the deal. Eight of the 16 were small investment banks certified as owned by women, minorities or military veterans.

Business 11 Dec 2023 | 11:00 PM

No global carbon price? Companies set their own

DUBAI: A growing list of global companies are setting a price or charging themselves for each tonne of their carbon emissions, looking to shape their investments and business for future pollution taxes or other new climate rules.

Technology 22 Sept 2023 | 05:18 AM

Big Pharma bets on AI to speed up clinical trials

LONDON (Reuters) - Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.

Banking 20 Aug 2024 | 05:24 AM

AmBank records 1Q net profit of RM500.2mil

KUALA LUMPUR: AMMB Holdings Bhd (AmBank) remains optimistic over its prospects for its 2025 financial year (FY25) after having observed the positive economic momentum across all sectors in 2024.

Corporate News 20 Aug 2024 | 11:00 PM

AmBank posts higher 1Q net profit at RM500mil

AMMB Holdings Bhd (AmBank) remains optimistic about its prospects for its financial year 2025 (FY25) after having observed the positive economic momentum across all sectors in 2024.

Corporate News 3 Aug 2020 | 10:02 AM

Rival drugmakers launch joint trial of medicines for Covid-19

RIVAL drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus.

Corporate News 27 Aug 2023 | 11:00 PM

FTC suspends objection to deal for Horizon Therapeutics

Washington: The US Federal Trade Commission (FTC) has suspended its challenge of Amgen’s US$27.8bil purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should settle the case, a filing late last Friday shows.

Markets 7 Aug 2024 | 01:22 PM

Wall St set to open higher as Big Tech buying continues

WALL Street was set to open higher on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week partly sparked heavy volatility in global markets.

Banking 29 May 2023 | 11:00 PM

AmBank ends FY23 on high note

PETALING JAYA: AMMB Holdings Bhd (AmBank Group is maintaining a bullish outlook on its prospects, despite potential external challenges such as the volatility in the global growth trajectory and heightening geopolitical tensions

Next Page
All Headlines:

Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In